Literature DB >> 12663767

Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection.

Jörg Schlender1, Gert Zimmer, Georg Herrler, Karl-Klaus Conzelmann.   

Abstract

Human respiratory syncytial virus (HRSV) and bovine RSV (BRSV) infect human beings and cattle in a species-specific manner. We have here analyzed the contribution of RSV envelope proteins to species-specific entry into cells. In contrast to permanent cell lines, primary cells of human or bovine origin, including differentiated respiratory epithelia, peripheral blood lymphocytes, and macrophages, showed a pronounced species-specific permissiveness for HRSV and BRSV infection, respectively. Recombinant BRSV deletion mutants lacking either the small hydrophobic (SH) protein gene or both SH and the attachment glycoprotein (G) gene retained their specificity for bovine cells, whereas corresponding mutants carrying the HRSV F gene specifically infected human cells. To further narrow the responsible region of F, two reciprocal chimeric F constructs were assembled from BRSV and HRSV F1 and F2 subunits. The specificity of recombinant RSV carrying only the chimeric F proteins strictly correlated with the origin of the membrane-distal F2 domain. A contribution of G to the specificity of entry could be excluded after reintroduction of BRSV or HRSV G. Virus with F1 and G from BRSV and with only F2 from HRSV specifically infected human cells, whereas virus expressing F1 and G from HRSV and F2 from BRSV specifically infected bovine cells. The introduction of G enhanced the infectiousness of both chimeric viruses to equal degrees. Thus, the role of the nominal attachment protein G is confined to facilitating infection in a non-species-specific manner, most probably by binding to cell surface glycosaminoglycans. The identification of the F2 subunit as the determinant of RSV host cell specificity facilitates identification of virus receptors and should allow for development of reagents specifically interfering with RSV entry.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663767      PMCID: PMC152164          DOI: 10.1128/jvi.77.8.4609-4616.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Cellular receptors for viruses: links to tropism and pathogenesis.

Authors:  J Schneider-Schaulies
Journal:  J Gen Virol       Date:  2000-06       Impact factor: 3.891

2.  Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture.

Authors:  Gert Zimmer; Karl-Klaus Conzelmann; Georg Herrler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

3.  Antigenic and molecular analyses of the variability of bovine respiratory syncytial virus G glycoprotein.

Authors:  D Prozzi; K Walravens; J P Langedijk; F Daus; J A Kramps; J J Letesson
Journal:  J Gen Virol       Date:  1997-02       Impact factor: 3.891

4.  Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus.

Authors:  Sunee Techaarpornkul; Peter L Collins; Mark E Peeples
Journal:  Virology       Date:  2002-03-15       Impact factor: 3.616

5.  Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry.

Authors:  R Bals; W Xiao; N Sang; D J Weiner; R L Meegalla; J M Wilson
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 6.  HIV-1 envelope determinants for cell tropism and chemokine receptor use.

Authors:  T L Hoffman; R W Doms
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

7.  Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G.

Authors:  S A Feldman; R M Hendry; J A Beeler
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.

Authors:  L K Hallak; D Spillmann; P L Collins; M E Peeples
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

9.  Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro.

Authors:  C Bourgeois; J B Bour; K Lidholt; C Gauthray; P Pothier
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.

Authors:  G N Rogers; J C Paulson; R S Daniels; J J Skehel; I A Wilson; D C Wiley
Journal:  Nature       Date:  1983 Jul 7-13       Impact factor: 49.962

View more
  28 in total

Review 1.  Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs.

Authors:  Tiffany A Peterson; Andrew G MacLean
Journal:  J Neuroimmune Pharmacol       Date:  2018-10-13       Impact factor: 4.147

Review 2.  Mucosal vaccines against respiratory syncytial virus.

Authors:  Kejian Yang; Steven M Varga
Journal:  Curr Opin Virol       Date:  2014-04-29       Impact factor: 7.090

3.  A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus.

Authors:  Gert Zimmer; Sascha Bossow; Larissa Kolesnikova; Matthias Hinz; Wolfgang J Neubert; Georg Herrler
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus.

Authors:  Jörg Schlender; Veit Hornung; Stefan Finke; Margit Günthner-Biller; Sabrina Marozin; Krzysztof Brzózka; Sharareh Moghim; Stefan Endres; Gunther Hartmann; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production.

Authors:  Antonius G P Oomens; Kevin P Bevis; Gail W Wertz
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

6.  Neurokinin-1 enables measles virus trans-synaptic spread in neurons.

Authors:  Nina R Makhortova; Peter Askovich; Catherine E Patterson; Lisa A Gechman; Norma P Gerard; Glenn F Rall
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

Review 7.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Differential sensitivity of differentiated epithelial cells to respiratory viruses reveals different viral strategies of host infection.

Authors:  Katherina Goris; Sabine Uhlenbruck; Christel Schwegmann-Wessels; Wiebke Köhl; Frank Niedorf; Michael Stern; Marion Hewicker-Trautwein; Robert Bals; Geraldine Taylor; Armin Braun; Gerd Bicker; Manfred Kietzmann; Georg Herrler
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

Review 9.  Structure and function of respiratory syncytial virus surface glycoproteins.

Authors:  Jason S McLellan; William C Ray; Mark E Peeples
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission.

Authors:  A G P Oomens; Gail W Wertz
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.